NCCN's 2026 guidelines recommend routine integration of AI-based 5-year breast cancer risk prediction from mammograms.
Key Details
- 1NCCN updated guidelines to recommend AI-based 5-year breast cancer risk assessment using routine mammograms.
- 2Patients with an AI-predicted 5-year risk ≥1.7% should be considered for supplemental imaging (MRI or ultrasound).
- 3Risk evaluations should begin at age 35, earlier than the previous standard of 40.
- 4Re-assessment over time is advised due to changes in breast tissue.
- 5The Clairity Breast platform, FDA-cleared for this purpose, is highlighted and is reportedly over 3x more accurate at risk prediction than density reporting by radiologists.
Why It Matters
These recommendations will likely accelerate adoption of AI tools in breast imaging, standardizing risk stratification and personalized screening. Radiologists and imaging providers must prepare for new workflows and patient stratification protocols based on AI outputs.
Source
Radiology Business
Related News
•Radiology Business
Pennsylvania Bill Mandates AI Use Disclosure in Healthcare Facilities
Pennsylvania House passes a bill requiring healthcare facilities, including imaging centers, to disclose their use of AI in clinical care.
•Radiology Business
Radiology Societies Urge Patient Safety in FDA Generative AI Regulation
RSNA and ACR call for patient safety and ongoing monitoring as the FDA considers regulations for generative AI in radiology.
•Radiology Business
New AI Flags Uncertainty in Breast Cancer Imaging Predictions
University of Pittsburgh researchers developed an AI model that quantifies uncertainty in breast cancer diagnostic predictions to enhance trustworthiness.